New device aims to speed up finger nerve healing
NCT ID NCT07524465
First seen Jun 25, 2026 · Last updated Aug 25, 2026 · Updated 3 times
Summary
This study is testing a device called ReFeel, which is used to repair damaged nerves in the fingers. The goal is to see if it helps people recover faster and with better results, like improved feeling and less pain. Only 5 adults with a specific type of finger nerve injury will be observed for up to 12 months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ReFeel device (a nerve repair device)
- What this could lead to
- If successful, this could point toward a better way to repair damaged nerves in fingers, potentially improving sensation and reducing pain.
- What could go wrong
- This is a very small study (only 5 people) and is observational, so results may not apply widely. The device is already approved, but its effectiveness for digital nerves is still being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 5 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-69 years * Digital nerve injury in at least one digit requiring repair with a gap of 1-25mm * Able to provide tension free end to end nerve coaptation * Have uninjured contralateral or adjacent digit that is suitable to serve as a referenced digit for baseline functional assessments. * Willing to comply with follow up for visits up to 12 months. Exclusion Criteria: * Estimated distance of recovery greater than 150 mm (from proximal site of to the tip of the digit) * Injury distal to distal interphalangeal joint * Extensive soft tissue injury that will impair recovery assessment * Incomplete nerve transections * Injury requiring replantation of the target digit * Injuries to the affected nerve proximal to the superficial arch * Nerve injuries \> 24 weeks after initial injury * End to side nerve repair * Injuries with vascular damage resulting in inadequate perfusion despite repair * Subjects with type 1 diabetes or type 2 diabetes requiring regular insulin therapy * Subjects who are undergoing or expected to undergo treatment with chemotherapy, radiation therapy, or other know treatment that affects the growth of neural and/or vascular system * History of neuropathy, diabetic neuropathy, or another known neuropathy * Excepted use of medication during the study that is known to impact nerve regeneration or cause peripheral neuropathy such as immunosuppressant's and Chemotherapeutic * History of chronic ischemic condition of the upper extremity. * Workers Compensation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Digital nerve injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
OrthoCarolina Research Institute
Charlotte, North Carolina, 28207, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.